Eli Lilly and Company ("Lilly") — Lilly Corporate Center, Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly; incorporated in Indiana in 1901. Publicly traded on the NYSE under ticker LLY. It is one of the largest research-based pharmaceutical companies, reporting 2024 revenue of approximately $45.0 billion and roughly 47,000–50,000 employees worldwide (Lilly 10-K / lilly.com). No parent company; it is the ultimate parent.
Operations. Lilly discovers, develops, manufactures, and markets human pharmaceutical products as a single business segment, selling in approximately 95 countries with manufacturing in the U.S. (including Puerto Rico), Europe, and Asia. Major therapy areas include diabetes (insulins such as Humalog and Humulin; Jardiance and related products through a global agreement with Boehringer Ingelheim), obesity and metabolic disease (tirzepatide brands Mounjaro and Zepbound), oncology, immunology (e.g., Taltz), and neuroscience (e.g., Cymbalta/duloxetine, Zyprexa/olanzapine). It also operates LillyDirect, a U.S. direct-to-consumer digital health platform. This is an operating company, not an NPE or licensing shell.
Litigation posture. Lilly is an operating company and a one-way patent plaintiff in this dataset: 8 tracked cases as plaintiff, 0 as defendant. All are Hatch-Waxman (ANDA) infringement suits against generic manufacturers, filed in Lilly's home venue, the U.S. District Court for the Southern District of Indiana (Indianapolis Division) — not a plaintiff-friendly NPE venue such as the Eastern District of Texas.
Notable cases. The tracked 2008 filings — against Sun Pharmaceutical, Lupin, Aurobindo, Wockhardt, Actavis Elizabeth, Impax, Sandoz, and Cobalt Laboratories — followed ANDA filings seeking approval of generic duloxetine hydrochloride (Cymbalta) capsules, then Lilly's second-best-selling drug, ahead of patent expiry in 2013. This framework also reflects Lilly's broader branded-drug defense program of that era, including olanzapine (Zyprexa) and duloxetine patent challenges in the U.S. and abroad.